没有MHC-II的小鼠抑制黑色素瘤:癌症免疫治疗的机制和影响
Hexin Shi1, Dawson Medler1, Jianhui Wang1
1Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center , Dallas, TX, USA.
The Journal of experimental medicine
|October 29, 2024
概括
一种消除MHCII类 (H2-Aa) 表达的突变增强了小鼠的抗黑色素瘤免疫力. 这种策略,特别是与检查点抑制相结合时,对癌症免疫治疗有希望.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 遗传学 遗传学 是一个
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中长期有效性有限.
- T细胞耗尽是限制ICI有效性的关键机制.
- 了解影响抗瘤免疫力的宿主遗传因素对于新疗法开发至关重要.
研究的目的:
- 为了确定对黑色素瘤产生抵抗力的宿主遗传因素.
- 调查MHCII类 (H2-Aa) 在抗瘤免疫中的作用.
- 探索MHC-II抑制在癌症中的治疗潜力.
主要方法:
- 在C57BL/6J小鼠中进行基因查,以确定黑色素瘤抗性突变.
- 在H2-Aa缺乏的小鼠中分析树突细胞 (DC) 种群 (cDC1,cDC2).
- 评估CD8 T细胞反应和瘤透.
- 单独和ICI一起评估H2-Aa破坏的治疗疗效.
主要成果:
- 在H2-Aa中发生的一种突变,编码MHCII类α链,赋予了强大的免疫介导抗性黑色素瘤.
- 在DCs中的H2-Aa缺乏改变了cDC1和cDC2种群的平衡,有利于cDC2.
- 缺乏H2-Aa的cDC2细胞是通过交叉启动和招募CD8T细胞来抑制黑色素瘤的关键.
- 在H2-Aa缺乏的小鼠中观察到降低的T调节细胞数量,有助于瘤抑制.
- 急性H2-Aa干扰在黑色素瘤携带的小鼠中表现出治疗效果,特别是在与ICI结合时.
结论:
- 特别是在DC中,MHCII类表达在调节抗瘤免疫力方面起着至关重要的作用.
- 向MHCII类代表了一种潜在的新型免疫治疗策略,用于增强癌症治疗.
- 将MHC-II抑制与ICI等现有疗法结合起来,可以克服治疗耐药性.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K


